The injection itself is quick and typically involves minimal discomfort, with our specialists ensuring you are comfortable throughout the process
is an employee of Mount Sinai, which receives research funds from Amgen, Anacor, Boehringer Ingelheim, Celgene, Lilly, Janssen Biotech, Kadmon, LEO Pharmaceuticals, Medimmune, Novartis, Pfizer, Sun Pharmaceuticals and Valeant
30 days (reconstituted) Mechanism Classification Primary Mechanism: NNMT (Nicotinamide N-methyltransferase) Inhibitor Target Enzyme: Nicotinamide N-methyltransferase Cellular Effect: Increases intracellular NAD+ and SAM levels Metabolic Pathway: NAD+ salvage pathway modulation Selectivity: Highly selective for NNMT (no cross-reactivity with related enzymes) Pharmacological Properties Route of Administration: Subcutaneous injection Bioavailability: High (subcutaneous)
Who Should Not Take GLP Therapy
All Reta products are intended strictly for research and laboratory use only and are not intended for human consumption
Common research-planning range Community discussions and protocol-style references commonly describe 1-2 mg per day SubQ for a 4-8 week cycle